A group of research scientists at the Experimental Tuberculosis Unit of the Fundació Institut Germans Trias i Pujol have created a vaccination that reduces the length of treatment of the latent infection which causes tuberculosis from nine months to only one...
Researchers at the Institute of Biotechnology and Biomedicine at the UAB have managed to develop a new protein, called NF795gpC, which acts as a sensor when it comes into contact with the serum of a patient infected by HIV (Human Immunodeficiency Virus) and allows it to be easily detected.
Researchers at the UAB have undertaken the EPICOLON project, in which they analysed 2,000 patients with colorectal cancers diagnosed over the year in 25 hospitals throughout Spain. As a result of this work they have defined hereditary syndrome clearly differentiated from...
Some of those who suffer a severe or moderate head injury experience a ventricular dilatation in the brain that may cause unnecessary suffering to patients. UAB Scientists have studied the origin of these ventricular dilatation. They have concluded that...
Crohn's disease and ulcerative colitis are two types of chronic inflammatory bowel diseases (IBDs) of unknown origin, which are characterized by phases of activity and remission that vary depending on the patient. In this thesis, the author has defined a new experimental model of chronic...
It is detected an increase of the diabetes prevalence in patients infected by the Hepatitis C virus (HCV), as well as a greater prevalence of infection by HCV in diabetic people. UAB researchers from the Endocrinology Department of the Hospital Vall d'Hebron review the information available and study the mechanisms by which HCV triggers the...
Before a pituitary tumour is operated on, there are three factors that make it possible to identify which patients are most likely to recover following surgery: the size of the tumour, the secretion system of the tumour and the experience of the neurosurgeons. This was the conclusion reached by a group of doctors from Sant Pau Hospital after...
Until now, it was known that, despite their benefits for preventing cardiovascular diseases, antiplatelet drugs could be damaging to the digestive system. The Catalan Institute of Pharmacology Foundation (FICF) has recently shown its incidence in patients who have a risk of upper grastrointestinal bleeding (UGIB).
Reasearchers of the UAB's Cellular Biology, Physiology and Immunology Departament, in collaboration with the Hospital of Mataró and the Fundació de Gastroenterology Dr. Vilardell, have identified for the first time the P2Y1 receptor, which is responsible of the purinergic relaxation in the human colon.
Studies on the brain are gradually unravelling the mysteries of how it operates.
...
